CN103055069A - External Chinese medicine composition for treating postherpetic neuralgia and preparation method of composition - Google Patents

External Chinese medicine composition for treating postherpetic neuralgia and preparation method of composition Download PDF

Info

Publication number
CN103055069A
CN103055069A CN2013100348937A CN201310034893A CN103055069A CN 103055069 A CN103055069 A CN 103055069A CN 2013100348937 A CN2013100348937 A CN 2013100348937A CN 201310034893 A CN201310034893 A CN 201310034893A CN 103055069 A CN103055069 A CN 103055069A
Authority
CN
China
Prior art keywords
parts
radix
preparation
medicine composition
chinese medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN2013100348937A
Other languages
Chinese (zh)
Other versions
CN103055069B (en
Inventor
李沛波
苏薇薇
王永刚
彭维
吴忠
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sun Yat Sen University
National Sun Yat Sen University
Original Assignee
National Sun Yat Sen University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by National Sun Yat Sen University filed Critical National Sun Yat Sen University
Priority to CN201310034893.7A priority Critical patent/CN103055069B/en
Publication of CN103055069A publication Critical patent/CN103055069A/en
Application granted granted Critical
Publication of CN103055069B publication Critical patent/CN103055069B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Abstract

The invention discloses an external Chinese medicine composition for treating postherpetic neuralgia and a preparation method of the composition. The external Chinese medicine composition is prepared from the following crude medicaments in parts by weight: 10-25 parts of spina gleditsiae, 3-9 parts of pseudo-ginseng, 3-6 parts of chrysanthemum, 3-6 parts of basil leaves, 3-15 parts of cortex lycii radicis, 3-9 parts of semen armeniacae amarae, 3-6 parts of rhizoma cimicifugae, 3-15 parts of red paeonia, 3-15 parts of toad, 3-6 parts of felwort, 1-3 parts of periostracum cicada, 10-30 parts of calcined concha margaritifera, 3-9 parts of lithospermum purpurocaeruleum, 3-9 parts of rhizoma arisaematis, 3-12 parts of angelica, 3-15 parts of cortex lycii radicis, 3-15 parts of radix sophorae flavescentis, 3-9 parts of angelica, 1-3 parts of wild ginger, 3-9 parts of corydalis tuber, 3-9 parts of Chinese lobelia, 1-3 parts of mint, 3-15 parts of ash bark, 3-15 parts of phellodendron amurense and 0.5-1.0 parts of borneol. A preparation method of the external Chinese medicine composition comprises the following steps: crushing the above raw materials into fine powder; and soaking in vegetable oil, and filtering to obtain oil. The external Chinese medicine composition has the advantages of remarkable curative effect, no adverse reaction, short treatment period, and is convenient for medical use and low expense.

Description

A kind of external medicine composition for the treatment of post-herpetic neuralgia and preparation method thereof
Technical field
The present invention relates to a kind of external medicine composition for the treatment of post-herpetic neuralgia and preparation method thereof.
Background technology
Herpes zoster is commonly called as " skirt-roof dragon ", " herpes zoster ", " herpes zoster " by a kind of disease that varicella zoster virus causes.Virus enters human body by respiratory mucosa, and this virus can be along peripheral nerve fiber generation herpes for having a liking for nerve.After varicella zoster virus infected, patient's pain time of 10% surpassed one month, as can not get in time treatment or malpractice, and pain can still exist after herpes disappears, the case pain that has even surpass many decades.Post-herpetic neuralgia is that herpes disappears, forms to still have in the zone of herpes zoster after the skin lesion 3~6 months and continues intractable pain and surpass 1 month person.Post-herpetic neuralgia is the clinical more common disease of Dermatology Outpatient Department and pain.But 10% Patients with Herpes Zoster Herpes Zoster post herpetic neuralgia is arranged approximately, and with gerontal patient's post-herpetic neuralgia incidence rate more than 60 years old for the highest, can reach 50%-75%.Along with the aging of population, the sickness rate of post-herpetic neuralgia can significantly increase.
The allodynia of post-herpetic neuralgia and the treatment of allodynia are very difficult, bring huge, long-term injury for patient's spirit and psychology.The postherpes neuralgia PHN patient that some is serious, light stimulation can cause the pain outbreak, the patient who has stimulates for reducing clothes, dare not wear the clothes.This allodynia reaction also can show as idiopathic pain, does not namely stimulate to touch pain also occurs often.The patient who also has is because of long-term pain emotion hypertonicity, and the spirit depressing that has is desperate.
Modern medicine thinks that post-herpetic neuralgia is because virus causes nervous dysfunction caused.Chinese medicine thinks that herpes zoster is that the spleen damp-stagnancy is of a specified duration because liver and gall fire is contained, and the diseases caused by exogenous pathogenic factor poison is evil and send out.Healthy energy interior-deficiency, evil malicious delay, qi depression to blood stasis, damp-heat accumulation, the stagnant resistance in network road then cause post-herpetic neuralgia, and add again the patient and be mostly old and the weakling, obstinate disease, asthenia of qi and blood declines, and does not support venation, has caused " to empty part, being the ground that stays heresy ".
The Therapeutic Method of doctor trained in Western medicine at present commonly used comprises: oral antiviral agents, non-steroidal anti-inflammatory analgesics, opiates medicine (slow releasing agent), antidepressants, antuepileptic, tranquilizer; Nerve block; The neural therapy etc. of damaging.And the traditional Chinese medical science often adopts the methods such as blood circulation promoting and blood stasis dispelling, dredging the meridian, poison holding putrefaction removing, heat-clearing and toxic substances removing, inrigorating qi and promoting blood circulation to be treated by determination for the treatment of based on pathogenesis obtained through differentiation of symptoms and signs.But most of traditional analgesic is all not satisfactory to the therapeutic effect of post-herpetic neuralgia, and treatment cost and appointed condition are higher.So that the doctor feels a delicacy about to the treatment of post-herpetic neuralgia for a long time.This pain has the bad reputation of " not dead cancer ".
Summary of the invention
For addressing the above problem, the present invention is based on the traditional Chinese medical science to understanding and the rule for the treatment of of post-herpetic neuralgia, employing has the Chinese medicine of the effects such as blood circulation promoting and blood stasis dispelling, dredging the meridian, poison holding putrefaction removing, heat-clearing and toxic substances removing, cooling blood and relieving pain, according to the theory of Chinese medical science prescription, a kind of external medicine composition for the treatment of post-herpetic neuralgia is provided, and preparation method thereof.
The objective of the invention is provides a kind of evident in efficacy, with low cost, preparation and uses the external medicine composition simple, that side effect is little, relapse rate is low for post-herpetic neuralgia.
Compositions of the present invention is made by following raw materials in part by weight: 10~25 parts of Spina Gleditsiaes, 3~9 parts of Radix Notoginseng, 3~6 parts of Flos Chrysanthemis, 3~6 parts of Folium Perillaes, 3~15 parts of Cortex Lycii, 3~9 parts of Semen Armeniacae Amarums, 3~6 parts of Rhizoma Cimicifugaes, 3~15 parts of Radix Paeoniae Rubra, 3~15 parts of Bufo siccuss, 3~6 parts of Radix Gentianaes, 1~3 part of Periostracum Cicadae, 10~30 parts of calcined Concha Margaritifera, 3~9 parts of Radix Arnebiae (Radix Lithospermi)s, 3~9 parts of Rhizoma Arisaematiss, 3~12 parts of Radix Angelicae Sinensis, 3~15 parts of Cortex Lycii, 3~15 parts of Radix Sophorae Flavescentiss, 3~9 parts of Radix Angelicae Sinensis, 1~3 part of Herba Asari, 3~9 parts of Rhizoma Corydalis, 3~9 parts of Herba Lobeliae Chinensis, 1~3 part of Herba Menthae, 3~15 parts of Cortex Fraxinis, 3~15 parts of Cortex Phellodendris, 0.5~1.0 part of Borneolum Syntheticum.
Wherein, optimization formula is: 15 parts of Spina Gleditsiaes, 6 parts of Radix Notoginseng, 3 parts of Flos Chrysanthemis, 3 parts of Folium Perillaes, 9 parts of Cortex Lycii, 9 parts of Semen Armeniacae Amarums, 6 parts of Rhizoma Cimicifugaes, 9 parts of Radix Paeoniae Rubra, 9 parts of Bufo siccuss, 6 parts of Radix Gentianaes, 3 parts of Periostracum Cicadaes, 20 parts of calcined Concha Margaritifera, 6 parts of Radix Arnebiae (Radix Lithospermi)s, 3 parts of Rhizoma Arisaematiss, 6 parts of Radix Angelicae Sinensis, 9 parts of Cortex Lycii, 9 parts of Radix Sophorae Flavescentiss, 6 parts of Radix Angelicae Sinensis, 3 parts of Herba Asaris, 6 parts of Rhizoma Corydalis, 6 parts of Herba Lobeliae Chinensis, 3 parts of Herba Menthaes, 9 parts of Cortex Fraxinis, 9 parts of Cortex Phellodendris, 1 part of Borneolum Syntheticum.
Preferred dosage form most preferably is the oil preparation of being made by the vegetable oil lixiviate for being fit to the exterior-applied formulations such as oil preparation, unguentum, liniment, tincture or gel of clinical practice.
Preparation method step of the present invention is as follows: above-mentioned raw materials is ground into fine powder by proportioning crosses 200 mesh sieves, place 50 ℃ of vegetable oil of 6 times of volumes to soak 5 hours the fine powder after sieving, cross leaching oil, cooling gets target product.
Described vegetable oil is Oleum Sesami, Oleum Arachidis hypogaeae semen, Oleum Glycines, safflower oil.
Make other exterior-applied formulations such as need, can be by making according to a conventional method the dosage form that needs behind the lixiviating effective components.
Using method of the present invention can be: get an amount of affected part of exterior coating.
Medicine and method with respect to existing treatment post-herpetic neuralgia have the following advantages:
The used raw material of Chinese medicine medicine of the present invention all is conventional Chinese medicines of putting down in writing in the state-promulgated pharmacopoeia, buys from the Chinese medicine shop easily; And preparation method is simple.
The external curing that the present invention is directed to post-herpetic neuralgia is very effective, this Chinese medicine composition is according to the principle-method-recipe-medicines principle of whole prescription of the traditional Chinese medical science, various crude drug coordinate at utmost to bring into play drug effect mutually, can blood circulation promoting and blood stasis dispelling, dredging the meridian, poison holding putrefaction removing, heat-clearing and toxic substances removing, cooling blood and relieving pain, significantly alleviate post-herpetic neuralgia and suppress recurrence, in addition, have also that analgesic effect is rapid-action and lasting, cure rate is high, relapse rate is low, have no adverse reaction, short treating period, the advantage such as medication is convenient, expense is cheap.Observe through 120 routine post-herpetic neuralgia patient clinicals, the average onset time of pain relieving is 25 minutes, and cure rate is 72%, total effective rate 92%, and relapse rate is 5%.
The specific embodiment
The present invention is described further below in conjunction with embodiment.
Embodiment 1: the preparation of external medicine composition
Take by weighing each raw medicinal material by following weight portion: 15 parts of Spina Gleditsiaes, 6 parts of Radix Notoginseng, 3 parts of Flos Chrysanthemis, 3 parts of Folium Perillaes, 9 parts of Cortex Lycii, 9 parts of Semen Armeniacae Amarums, 6 parts of Rhizoma Cimicifugaes, 9 parts of Radix Paeoniae Rubra, 9 parts of Bufo siccuss, 6 parts of Radix Gentianaes, 3 parts of Periostracum Cicadaes, 20 parts of calcined Concha Margaritifera, 6 parts of Radix Arnebiae (Radix Lithospermi)s, 3 parts of Rhizoma Arisaematiss, 6 parts of Radix Angelicae Sinensis, 9 parts of Cortex Lycii, 9 parts of Radix Sophorae Flavescentiss, 6 parts of Radix Angelicae Sinensis, 3 parts of Herba Asaris, 6 parts of Rhizoma Corydalis, 6 parts of Herba Lobeliae Chinensis, 3 parts of Herba Menthaes, 9 parts of Cortex Fraxinis, 9 parts of Cortex Phellodendris, 1 part of Borneolum Syntheticum.Above-mentioned raw materials is ground into fine powder by proportioning crosses 200 mesh sieves, place 50 ℃ of Oleum Sesami of 6 times of volumes to soak 5 hours the fine powder after sieving, cross leaching oil, cooling gets target product.
External medicine composition is used for 120 routine post-herpetic neuralgia patients' clinical treatment and sums up
1, physical data: treatment group 120 examples, male 76 examples, women 44 examples.Minimum 46 years old of age, maximum 83 years old, average 66.5 years old; The course of disease is the shortest 65 days, and is the longest 62 months, and pathological changes is positioned at Head And Face 38 examples, upper limb 18 examples, back breast abdomen 64 examples.Selected lesions of patients is all fully recovered, without open wound, and equal readme skin lesion place pain endurable.And before treatment, all accepted multiple Comprehensive Treatment.
2, case is selected
2.1 inclusion criteria: pain person was still left in 4 all parts after the clinical skin lesion that meets 5 traditional Chinese medical science disease Standardization of diagnosis and curative effects, 6 diagnosis of herpes zoster standards disappeared.
2.2 exclusion standard: get rid of autoimmune disease, malignant tumor, severe infections etc.
3, Therapeutic Method: along herpes pain band coating, every day 3 times, the person of having an intense pain is every 4 hours coatings 1 time, and 15 days is 1 course for the treatment of, carries out the curative effect statistics after treating continuously 2 courses for the treatment of.
4, observation index: with reference to the criterion of therapeutical effect of herpes zoster in " traditional Chinese medical science disease Standardization of diagnosis and curative effect ", carry out efficacy evaluation according to indexs such as pain disappearing times behind pain, sleep, daily life situation and the each coating.Recovery from illness: pain disappears substantially, and sleep is normal, and the daily life situation is normal; Produce effects: pain obviously alleviates, and sleep, daily life situation are significantly improved; Take a turn for the better: pain relief, sleep, daily life situation slightly are improved; Invalid: pain is not improved, and sleep, the daily life situation is poor.Count effective percentage with recovery from illness, produce effects and improvement.And average pain disappearing time behind the statistics coating.
5, untoward reaction and prognosis: the clinical adverse of patient's changes of vital signs and appearance in the record therapeutic process.And at treatment further consultation in rear 1 year and Effect of follow-up visit by telephone to observe patient's prognosis.
6, therapeutic outcome: when 120 routine patients finished through 2 courses for the treatment of, 86 examples of fully recovering; Produce effects 14; 10 examples take a turn for the better; Invalid 10 examples.Cure rate is 72%, total effective rate 92%.Pain disappearing time is 25 minutes behind each coating.In treatment, there is 1 example the reversibility untoward reaction to occur, main manifestations is the slight erythema of medication local skin, burning sensation, occurs in treatment the 3rd day, reduces the coating number of times and does not do special handling, disappears voluntarily continual cure after 3 days.After 2 course of therapy 1 year, 6 example recurrences are arranged, relapse rate is 5%, but pain degree obviously alleviates before treating, and continuing the medication symptom can very fast alleviation.
Experimental results show that above-mentioned composition still has preferably curative effect with Oleum Arachidis hypogaeae semen, Oleum Glycines, the lixiviate of Semen Flos Carthami wet goods vegetable oil.

Claims (5)

1. external medicine composition for the treatment of post-herpetic neuralgia, it is characterized in that: described compositions is made by following raw materials in part by weight: 10~25 parts of Spina Gleditsiaes, 3~9 parts of Radix Notoginseng, 3~6 parts of Flos Chrysanthemis, 3~6 parts of Folium Perillaes, 3~15 parts of Cortex Lycii, 3~9 parts of Semen Armeniacae Amarums, 3~6 parts of Rhizoma Cimicifugaes, 3~15 parts of Radix Paeoniae Rubra, 3~15 parts of Bufo siccuss, 3~6 parts of Radix Gentianaes, 1~3 part of Periostracum Cicadae, 10~30 parts of calcined Concha Margaritifera, 3~9 parts of Radix Arnebiae (Radix Lithospermi)s, 3~9 parts of Rhizoma Arisaematiss, 3~12 parts of Radix Angelicae Sinensis, 3~15 parts of Cortex Lycii, 3~15 parts of Radix Sophorae Flavescentiss, 3~9 parts of Radix Angelicae Sinensis, 1~3 part of Herba Asari, 3~9 parts of Rhizoma Corydalis, 3~9 parts of Herba Lobeliae Chinensis, 1~3 part of Herba Menthae, 3~15 parts of Cortex Fraxinis, 3~15 parts of Cortex Phellodendris, 0.5~1.0 part of Borneolum Syntheticum.
2. compositions according to claim 1, it is characterized in that: the weight portion proportioning of described raw material is: 15 parts of Spina Gleditsiaes, 6 parts of Radix Notoginseng, 3 parts of Flos Chrysanthemis, 3 parts of Folium Perillaes, 9 parts of Cortex Lycii, 9 parts of Semen Armeniacae Amarums, 6 parts of Rhizoma Cimicifugaes, 9 parts of Radix Paeoniae Rubra, 9 parts of Bufo siccuss, 6 parts of Radix Gentianaes, 3 parts of Periostracum Cicadaes, 20 parts of calcined Concha Margaritifera, 6 parts of Radix Arnebiae (Radix Lithospermi)s, 3 parts of Rhizoma Arisaematiss, 6 parts of Radix Angelicae Sinensis, 9 parts of Cortex Lycii, 9 parts of Radix Sophorae Flavescentiss, 6 parts of Radix Angelicae Sinensis, 3 parts of Herba Asaris, 6 parts of Rhizoma Corydalis, 6 parts of Herba Lobeliae Chinensis, 3 parts of Herba Menthaes, 9 parts of Cortex Fraxinis, 9 parts of Cortex Phellodendris, 1 part of Borneolum Syntheticum.
3. the dosage form of compositions according to claim 1 and 2 is external-use oil preparation, unguentum, liniment, tincture or gel.
4. the preparation method of claim 1 or 2 described compositionss, comprise the steps: that above-mentioned raw materials is ground into fine powder by proportioning crosses 200 mesh sieves, place 50 ℃ of vegetable oil of 6 times of volumes to soak 5 hours the fine powder after sieving, cross leaching oil, cooling gets target product.
5. preparation method according to claim 4 is characterized in that described vegetable oil is Oleum Sesami, Oleum Arachidis hypogaeae semen, Oleum Glycines or safflower oil.
CN201310034893.7A 2013-01-29 2013-01-29 External Chinese medicine composition for treating postherpetic neuralgia and preparation method of composition Active CN103055069B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201310034893.7A CN103055069B (en) 2013-01-29 2013-01-29 External Chinese medicine composition for treating postherpetic neuralgia and preparation method of composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310034893.7A CN103055069B (en) 2013-01-29 2013-01-29 External Chinese medicine composition for treating postherpetic neuralgia and preparation method of composition

Publications (2)

Publication Number Publication Date
CN103055069A true CN103055069A (en) 2013-04-24
CN103055069B CN103055069B (en) 2014-04-23

Family

ID=48098164

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201310034893.7A Active CN103055069B (en) 2013-01-29 2013-01-29 External Chinese medicine composition for treating postherpetic neuralgia and preparation method of composition

Country Status (1)

Country Link
CN (1) CN103055069B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103705614A (en) * 2013-12-16 2014-04-09 李慧 Traditional Chinese medicine for treating herpes zoster
CN103961425A (en) * 2014-05-16 2014-08-06 姚学文 Gentian-arenobufagin herpes diminishing external liquid and application thereof
CN105902715A (en) * 2016-07-13 2016-08-31 王云龙 Externally applied traditional Chinese medicine for treating herpes zoster

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101773651A (en) * 2010-04-19 2010-07-14 泰一和浦(北京)中医药研究院有限公司 Chinese medicine composition for treating headache and preparation method thereof
CN102430099A (en) * 2012-01-04 2012-05-02 揭静华 Life-prolonging essence

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101773651A (en) * 2010-04-19 2010-07-14 泰一和浦(北京)中医药研究院有限公司 Chinese medicine composition for treating headache and preparation method thereof
CN102430099A (en) * 2012-01-04 2012-05-02 揭静华 Life-prolonging essence

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
谢翠英等: "文少芳主任医师治疗带状疱疹后遗神经痛经验介绍", 《新中医》 *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103705614A (en) * 2013-12-16 2014-04-09 李慧 Traditional Chinese medicine for treating herpes zoster
CN103705614B (en) * 2013-12-16 2015-03-25 李慧 Traditional Chinese medicine for treating herpes zoster
CN103961425A (en) * 2014-05-16 2014-08-06 姚学文 Gentian-arenobufagin herpes diminishing external liquid and application thereof
CN103961425B (en) * 2014-05-16 2016-08-24 姚学文 Dragon toad bleb disappears external use liquid and application thereof
CN105902715A (en) * 2016-07-13 2016-08-31 王云龙 Externally applied traditional Chinese medicine for treating herpes zoster

Also Published As

Publication number Publication date
CN103055069B (en) 2014-04-23

Similar Documents

Publication Publication Date Title
CN103405683B (en) Traditional Chinese medicine composition for treating verruca plana
CN103055069B (en) External Chinese medicine composition for treating postherpetic neuralgia and preparation method of composition
CN100588418C (en) A Chinese medicine for treating skin disease of fur-bearing animal and preparation process thereof
CN103690620A (en) Externally-used traditional Chinese medicinal compound composition for treating rheumatoid arthritis and preparation method thereof
CN101816712B (en) Chinese medicinal composition for treating trigeminal neuralgia
CN103721230A (en) Traditional Chinese medicinal composition for treating liver cancer
CN102657785A (en) Medicinal composition for treating gingivitis
CN101129425B (en) Traditional Chinese medicine for treating zoster
CN101422577B (en) External traditional Chinese medicine for treating scald and burn and preparation method thereof
CN101879295B (en) Chinese medicinal psoriasis-eliminating decoction for treating blood stasis type psoriasis
CN104324135A (en) Traditional Chinese medicine composition for treating ischemic stroke and preparation method and application of traditional Chinese medicine composition
CN110934926A (en) Application of oil of Liaopo mountain hundred herb in preparing medicine for treating arthralgia
CN104547619A (en) Traditional Chinese medicine for treating apoplexy sequela paralytic limbs and preparation method of traditional Chinese medicine
CN104055925A (en) Traditional Chinese medicine composition for treating diabetic peripheral neuropathy
CN104288604B (en) A kind of Chinese medicine composition for treating cerebral infarction
CN103285300A (en) Medicinal composition for treating stress incontinence
CN102526385A (en) Medicament for treating climacteric syndrome
CN102716183B (en) Traditional Chinese medicine for treating scapulohumeral periarthritis
CN102631633B (en) Preparation method for traditional Chinese medicine wash lotion for treating constipation type acute lymphangitis
CN102805795B (en) Chinese medicinal composition for treating acute soft tissue injury of chest and hypochondrium and application thereof
CN105362519A (en) Traditional Chinese medicinal composition for treating chloasma
CN105434890A (en) Radiation stomatitis treating traditional Chinese medicine composition
CN1308952A (en) Chinese medicine for treating trigeminal neuraligia and its preparing process
CN105106786A (en) Traditional Chinese medicine composition capable of dredging collaterals and relaxing muscles as well as preparation and production method of composition
CN103055148B (en) Traditional Chinese medicine composition for preventing and treating acne and sequelae stain and cicatrisation, and preparation method thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant